Print Friendly, PDF & Email

NCT/Study#

NCT04623775 /

CA224-104

A Study Of Relatlimab Plus Nivolumab In Combination With Chemotherapy Vs. Nivolumab In Combination With Chemotherapy In Participants With Stage IV Or Recurrent NSCLC

DISEASE GROUP:
Lung Cancer Clinical Trials
current phase:
II
STUDY STATUS:
Accepting Patients
Location:
Little Silver, NJ
For More information: